NCT00070031 2013-12-19
Edotecarin in Treating Women With Locally Advanced or Metastatic Breast Cancer That Has Not Responded to Chemotherapy
National Cancer Institute (NCI)
Phase 2 Completed
Clinical Trials
3 trialsNCT00067314 2012-01-18
Study in Women With Metastatic Breast Cancer Whose Cancer Has Gotten Worse After Anthracycline and Taxane Therapy
Pfizer
Phase 2 Completed
NCT00087503 2008-04-01
Intravenous Edotecarin in Patients With Advanced Gastric Cancer That Has Progressed or Recurred After Chemotherapy
Pfizer
Phase 2 Completed